Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer

NCT01126216 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

221

Enrollment

OTHER

Sponsor class

Stopped After an Interims analysis the Data Safety Monitoring board recommended this because no significant difference between the two arms was seen and was not expected with an reasonable recruitment of patients. No interruptions of the trial were made.

Conditions

Head and Neck Cancer

Interventions

DRUG: Paclitaxel/Cisplatin
RADIATION: Reduced RT
DRUG: 5-FU/Cisplatin
RADIATION: Standard RT

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]